Medical termination of pregnancy from day 85 to day 153 of gestation: A randomized comparison between administration of the initial dose of misoprostol at home or in the clinic

Abstract

Study ProtocolObjectivesThe objective of this study is to compare two groups of women requiring termination of pregnancy from the gestational age of 85 days. All women will receive Mifepristone during their first visit to the out-patient ward. One group of women will receive Misoprostol to administer the first dose (vaginally) at home and 2 hours later they will be admitted to the in-patient ward. They will be informed to present earlier if they start bleeding or experience pain corresponding to more than normal menstrual cramping.The other group will receive the first dose of Misoprostol (vaginally) when admitted in the in-patient ward (usually in the morning) according to current practice.Primary objectiveTo investigate the proportion of women who are successfully treated as day-care patients (day-care being defined as 9 hours from time of admission).DesignThe study will be a randomized, controlled, multi-centred open label trial with women recruited from four hospitals in Sweden.